Etterschlag, Bavaria, Germany
With 30+ years of experience, I contribute to advancing bioprocessing and drug manufacturing as Director / Manager at various companies. My focus lies in leading applied research and development initiatives, spanning from gene(s) to drug products, while driving automation, analytics and digital transformation in the bioprocessing value chain. By fostering cross-functional collaboration and leveraging expertise in bioinformatics, biostatistics, bioprocessing and program management, I aim to accelerate the transfer of innovative technologies and drug candidates to manufacturing. Passionate about enhancing patient outcomes, I also share insights on "Quality by Design" through university lectures, inspiring the next generation of biotech professionals.
my mission: take on a central leadership role within Coriolis scientific organization (leadership & development: people, science, technology); define, drive & execute internal/external research initiatives and technology collaborations in close coordination with board members/aligned to company's strategy; act as a key interface between the group, internal stakeholders, and external partners, fostering effective cross-functional science & technology collaborations; drive the transfer of methods and results from research projects into Operations for application in client projects; do some scientific marketing
Program/project lead for applied research & development in mRNA bio-processing - from DNA, via drug substance to drug product - (including the transfer of developed process technologies (non-GMP) to manufacturing (GMP)). Fostering & accelerating the transfer of drug candidates by using automation and digital transformative steps in the drug manufacturing value chain. Being creative innovative, being targeted, being purpose-led, and being inspiring in collaborative efforts the development of newest technology (ies) and new drugs will help to improve the patient's quality of life. Thus lecturing "Quality by Design" at Universities (Biberach/Aalen) is supporting the development of the next generation of scientists.
Innovation & IP Management, Programme Lead, Principle Investigator for disruptive, applied research & development in bioprocessing and other future modalities (industrial-industrial, industrial-academic collaborations) to foster & accelerate the translation of biomolecules from nucleotide to bench/bedside use, pushing state-of-the art boundaries towards highest quality and more digitalisation in bioprocessing; active advisory member of various scientific committees in UK & D.: lecturing topic QbD (basics & applications) at HBC Biberach/Aalen
Principle Investigator / Group Leader / Technical Project Lead / Manager for disruptive biological based research (biomolecules and chemicals) and FMCG application - bioprocessing - from gene to final product, biocatalysis, biomolecules: structure-function relationship/characterisation, stability, formulation w/o automation. Scientific Lead in Biotechnology/Biochemistry, Member of various advisory boards., several innovative Ecosystems established and thereby several £mio of governmental research funding secured; strong experience in multi partner contract negotiations
Group Leader and Project Team Senior Manager for the development of CE-IVD and FDA approved in-vitro diagnostic assays - developed in conjunction with bespoke APIs (large, small molecules) - custom manufactured; cGMP conform bioprocesses developed for enzymes being ingredients of medical device toolboxes. people, programme and budget lead.